Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease
Source
Cardiovascular diabetology - ISSN 1475-2840-24:1 (2025) p. 1-11
Comparison of diagnostic accuracy and utility of non-invasive tests for clinically significant liver disease in a general population with metabolic dysfunction
Source
Hepatology - ISSN 0270-9139- (2025) p.
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
Source
JHEP Reports - ISSN 2589-5559-7:6 (2025) p. 1-16
Non-invasive tests for fibrotic MASH for reducing screen failure in therapeutic trials
Source
JHEP Reports - ISSN 2589-5559-7:4 (2025) p. 1-11
Metabolic dysfunction and alcohol-related liver disease (MetALD) : position statement by an expert panel on alcohol-related liver disease
Source
Journal of hepatology - ISSN 0168-8278-82:4 (2025) p. 744-756